AU2002302147A1 - Pharmaceutical composition - Google Patents
Pharmaceutical compositionInfo
- Publication number
- AU2002302147A1 AU2002302147A1 AU2002302147A AU2002302147A AU2002302147A1 AU 2002302147 A1 AU2002302147 A1 AU 2002302147A1 AU 2002302147 A AU2002302147 A AU 2002302147A AU 2002302147 A AU2002302147 A AU 2002302147A AU 2002302147 A1 AU2002302147 A1 AU 2002302147A1
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01500277 | 2001-11-23 | ||
| EP01500277.7 | 2001-11-23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002302147A1 true AU2002302147A1 (en) | 2003-06-12 |
| AU2002302147B2 AU2002302147B2 (en) | 2005-01-20 |
Family
ID=8183502
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002302147A Ceased AU2002302147B2 (en) | 2001-11-23 | 2002-11-21 | Pharmaceutical composition |
| AU2002338950A Abandoned AU2002338950A1 (en) | 2001-11-23 | 2002-11-21 | Coated particulate cefuroxime axetil compositions |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002338950A Abandoned AU2002338950A1 (en) | 2001-11-23 | 2002-11-21 | Coated particulate cefuroxime axetil compositions |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US20030161888A1 (en) |
| EP (1) | EP1446126B1 (en) |
| JP (1) | JP3497503B2 (en) |
| KR (1) | KR100979328B1 (en) |
| CN (1) | CN1297274C (en) |
| AT (1) | ATE473006T1 (en) |
| AU (2) | AU2002302147B2 (en) |
| BE (2) | BE1015217A5 (en) |
| BR (1) | BR0204767A (en) |
| CA (1) | CA2408198C (en) |
| CH (1) | CH693982A5 (en) |
| CO (1) | CO5580783A2 (en) |
| CY (1) | CY1110778T1 (en) |
| CZ (1) | CZ12993U1 (en) |
| DE (3) | DE10254412A1 (en) |
| DK (1) | DK1446126T3 (en) |
| ES (2) | ES2201932B2 (en) |
| FR (1) | FR2832635B1 (en) |
| GB (1) | GB2383536B (en) |
| GR (1) | GR1004522B (en) |
| HR (2) | HRP20020924A2 (en) |
| HU (1) | HUP0204026A3 (en) |
| IL (2) | IL161972A0 (en) |
| IT (1) | ITMI20022470A1 (en) |
| MX (1) | MXPA02011561A (en) |
| NO (1) | NO335273B1 (en) |
| NZ (1) | NZ533092A (en) |
| PL (1) | PL205325B1 (en) |
| PT (1) | PT1446126E (en) |
| RU (1) | RU2241460C2 (en) |
| SI (1) | SI1446126T1 (en) |
| TR (1) | TR200202559A2 (en) |
| WO (1) | WO2003043638A1 (en) |
| ZA (1) | ZA200209473B (en) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8071128B2 (en) | 1996-06-14 | 2011-12-06 | Kyowa Hakko Kirin Co., Ltd. | Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
| US9358214B2 (en) | 2001-10-04 | 2016-06-07 | Adare Pharmaceuticals, Inc. | Timed, sustained release systems for propranolol |
| US8367111B2 (en) | 2002-12-31 | 2013-02-05 | Aptalis Pharmatech, Inc. | Extended release dosage forms of propranolol hydrochloride |
| US8383154B2 (en) | 2004-05-11 | 2013-02-26 | Egalet A/S | Swellable dosage form comprising gellan gum |
| US8747895B2 (en) | 2004-09-13 | 2014-06-10 | Aptalis Pharmatech, Inc. | Orally disintegrating tablets of atomoxetine |
| US9884014B2 (en) | 2004-10-12 | 2018-02-06 | Adare Pharmaceuticals, Inc. | Taste-masked pharmaceutical compositions |
| EP2417969A1 (en) | 2004-10-21 | 2012-02-15 | Aptalis Pharmatech, Inc. | Taste-masked pharmaceutical compositions with gastrosoluble pore-formers |
| US20060105038A1 (en) * | 2004-11-12 | 2006-05-18 | Eurand Pharmaceuticals Limited | Taste-masked pharmaceutical compositions prepared by coacervation |
| JP2012107060A (en) * | 2004-12-15 | 2012-06-07 | Aska Pharmaceutical Co Ltd | Oral formulation in which bitter taste of isosorbide was alleviated, method for producing the same |
| JP4972311B2 (en) * | 2004-12-15 | 2012-07-11 | あすか製薬株式会社 | Oral preparation with reduced bitter taste of isosorbide and method for producing the same |
| DE102005019458A1 (en) | 2005-04-25 | 2006-10-26 | Grünenthal GmbH | Composition, useful in the preparation of pellets and the multi-particular-presentation form, comprises cefuroximaxetil and carrageenan of the group of lambda carrageenan, tau carrageenan and kappa carrageenan |
| US9161918B2 (en) | 2005-05-02 | 2015-10-20 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
| CN100402035C (en) * | 2005-07-07 | 2008-07-16 | 石药集团中奇制药技术（石家庄）有限公司 | A pharmaceutical composition of microencapsulated cefuroxime axetil |
| US20070281014A1 (en) * | 2006-06-01 | 2007-12-06 | Cima Labs, Inc. | Prednisolone salt formulations |
| US8637076B2 (en) * | 2006-06-01 | 2014-01-28 | Cima Labs Inc. | Prednisolone salt formulations |
| CN101756906B (en) * | 2009-11-02 | 2011-11-16 | 严洁 | Pharmaceutical composition of cefcapene pivoxil hydrochloride granules and preparation method thereof |
| TWI471146B (en) | 2009-12-02 | 2015-02-01 | Aptalis Pharma Ltd | Fexofenadine microcapsules and compositions containing them |
| WO2011085181A1 (en) * | 2010-01-08 | 2011-07-14 | Eurand, Inc. | Taste masked topiramate composition and an orally disintegrating tablet comprising the same |
| EP2566458B1 (en) | 2010-05-04 | 2015-08-05 | Mahmut Bilgic | Pharmaceutical formulations compising cefuroxime axetil |
| JP5853461B2 (en) * | 2010-07-30 | 2016-02-09 | 大正製薬株式会社 | Oral solution |
| EP2741750A1 (en) | 2011-08-12 | 2014-06-18 | Dhanuka Laboratories Ltd. | Pharmaceutical composition comprising cefuroxime |
| CN102440960A (en) * | 2011-09-01 | 2012-05-09 | 山东鲁抗医药股份有限公司 | Cefuroxime axetil dry suspension pharmaceutical composition and preparation method thereof |
| JP6200893B2 (en) | 2011-10-31 | 2017-09-20 | ノバルティス アーゲー | Pazopanib formulation |
| CN108338936A (en) * | 2017-01-23 | 2018-07-31 | 刘全忠 | The preparation and use of sensitive skin protective lotion |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1323161A (en) * | 1970-02-16 | 1973-07-11 | Wyeth John & Brother Ltd | Penicillin composition |
| GB1571683A (en) * | 1976-02-16 | 1980-07-16 | Glaxo Operations Ltd | Ester derivatives of cefuroxime |
| CA1094545A (en) * | 1976-02-16 | 1981-01-27 | Michael Gregson | Cephalosporin antibiotics |
| YU44680B (en) * | 1982-07-30 | 1990-12-31 | Glaxo Lab Ltd | Process for obtaining very pure amorphous form of cephuroxim axetile |
| GB8320520D0 (en) * | 1983-07-29 | 1983-09-01 | Glaxo Group Ltd | Chemical process |
| GB8524001D0 (en) * | 1985-09-30 | 1985-11-06 | Glaxo Group Ltd | Pharmaceutical composition |
| NL193682C (en) * | 1987-05-14 | 2000-07-04 | Glaxo Group Ltd | Coated Cefuroxime Maxetil Composition. |
| US4992276A (en) * | 1988-12-14 | 1991-02-12 | Warner-Lambert Company | Antiseptic compositions containing hexahydro-5-pyrimidinamine compounds and thymol and methods for preparing same |
| KR0168715B1 (en) * | 1992-11-30 | 1999-01-15 | 밋첼 아이. 커시너 | Tastemasked pharmaceutical materials |
| IT1277426B1 (en) * | 1995-08-03 | 1997-11-10 | Acs Dobfar Spa | BIOAVAILABLE CRYSTALLINE FORM OF CEFUROXIMA AXETIL |
| NZ299077A (en) * | 1996-07-26 | 1998-06-26 | Apotex Inc | Preparation of amorphous cefuroxime axetil (a cephalosporin derivative) by dissolving crystalline cefuroxim axetil in a highly polar solvent, typically dmso and/or dmf |
| ES2565163T3 (en) * | 1996-10-28 | 2016-03-31 | General Mills, Inc. | Imbibition and encapsulation of controlled release particles and encapsulated product |
| CA2209868C (en) * | 1997-08-15 | 2001-08-14 | Bernard Charles Sherman | Pharmaceutical compositions comprising cefuroxime axetil |
| GB9726781D0 (en) * | 1997-12-19 | 1998-02-18 | Glaxo Group Ltd | Pharmaceutical composition |
| AT413647B (en) * | 1998-11-26 | 2006-04-15 | Sandoz Ag | USE OF A COPOLYMERISATE OF 1-VINYL-2-PYRROLIDONE AND VINYL ACETATE FOR THE PREPARATION OF CEFUROXIMAXETIL-SUBJECTED TABLETS |
-
2002
- 2002-11-20 HR HR20020924A patent/HRP20020924A2/en not_active Application Discontinuation
- 2002-11-20 ES ES200202670A patent/ES2201932B2/en not_active Expired - Fee Related
- 2002-11-20 HR HR20020923A patent/HRP20020923A2/en not_active Application Discontinuation
- 2002-11-20 CZ CZ200213690U patent/CZ12993U1/en not_active IP Right Cessation
- 2002-11-21 WO PCT/EP2002/013150 patent/WO2003043638A1/en not_active Application Discontinuation
- 2002-11-21 IT IT002470A patent/ITMI20022470A1/en unknown
- 2002-11-21 FR FR0214587A patent/FR2832635B1/en not_active Expired - Fee Related
- 2002-11-21 ES ES02777359T patent/ES2347536T3/en not_active Expired - Lifetime
- 2002-11-21 GR GR20020100506A patent/GR1004522B/en unknown
- 2002-11-21 EP EP02777359A patent/EP1446126B1/en not_active Expired - Lifetime
- 2002-11-21 IL IL16197202A patent/IL161972A0/en unknown
- 2002-11-21 KR KR1020047007847A patent/KR100979328B1/en active IP Right Grant
- 2002-11-21 NZ NZ533092A patent/NZ533092A/en not_active IP Right Cessation
- 2002-11-21 ZA ZA200209473A patent/ZA200209473B/en unknown
- 2002-11-21 TR TR2002/02559A patent/TR200202559A2/en unknown
- 2002-11-21 MX MXPA02011561A patent/MXPA02011561A/en active IP Right Grant
- 2002-11-21 CH CH01954/02A patent/CH693982A5/en not_active IP Right Cessation
- 2002-11-21 PL PL357259A patent/PL205325B1/en unknown
- 2002-11-21 GB GB0227215A patent/GB2383536B/en not_active Expired - Fee Related
- 2002-11-21 PT PT02777359T patent/PT1446126E/en unknown
- 2002-11-21 BE BE2002/0668A patent/BE1015217A5/fr not_active IP Right Cessation
- 2002-11-21 AU AU2002302147A patent/AU2002302147B2/en not_active Ceased
- 2002-11-21 CA CA002408198A patent/CA2408198C/en not_active Expired - Lifetime
- 2002-11-21 US US10/301,452 patent/US20030161888A1/en not_active Abandoned
- 2002-11-21 DK DK02777359.7T patent/DK1446126T3/en active
- 2002-11-21 CN CNB021522375A patent/CN1297274C/en not_active Expired - Lifetime
- 2002-11-21 RU RU2002131380/15A patent/RU2241460C2/en active
- 2002-11-21 JP JP2002337570A patent/JP3497503B2/en not_active Expired - Fee Related
- 2002-11-21 BR BR0204767-5A patent/BR0204767A/en not_active IP Right Cessation
- 2002-11-21 DE DE10254412A patent/DE10254412A1/en not_active Withdrawn
- 2002-11-21 AT AT02777359T patent/ATE473006T1/en active
- 2002-11-21 DE DE20218068U patent/DE20218068U1/en not_active Expired - Lifetime
- 2002-11-21 SI SI200230920T patent/SI1446126T1/en unknown
- 2002-11-21 HU HU0204026A patent/HUP0204026A3/en unknown
- 2002-11-21 DE DE60236952T patent/DE60236952D1/en not_active Expired - Lifetime
- 2002-11-21 BE BE2002/0667A patent/BE1014078A6/en not_active IP Right Cessation
- 2002-11-21 AU AU2002338950A patent/AU2002338950A1/en not_active Abandoned
-
2004
- 2004-05-13 IL IL161972A patent/IL161972A/en active IP Right Grant
- 2004-05-18 CO CO04045861A patent/CO5580783A2/en not_active Application Discontinuation
- 2004-06-22 NO NO20042620A patent/NO335273B1/en not_active IP Right Cessation
-
2010
- 2010-09-13 CY CY20101100828T patent/CY1110778T1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU781269C (en) | Pharmaceutical compositions | |
| AU2002313236A1 (en) | Medicinal compositions | |
| EP1450824A4 (en) | Pharmaceutical composition | |
| AU2003291103A1 (en) | Pharmaceutical composition | |
| AU2001250420A1 (en) | Pharmaceutical compositions | |
| AU2001274307A1 (en) | Pharmaceutical compositions | |
| AU2002302147A1 (en) | Pharmaceutical composition | |
| AU2002257582A1 (en) | Pharmaceutical formulation | |
| AU2003250372A1 (en) | Pharmaceutical composition | |
| GB0117057D0 (en) | Pharmaceutical composition | |
| AU2002258221A1 (en) | Medicinal composition | |
| EP1408896A4 (en) | Pharmaceutical composition | |
| AU2001273919A1 (en) | Pharmaceutical compositions | |
| GB0116107D0 (en) | Pharmaceutical composition | |
| GB0127805D0 (en) | Pharmaceutical composition | |
| AU4085201A (en) | Pharmaceutical composition | |
| AU2002354460A1 (en) | Medicinal composition | |
| AU3586401A (en) | Pharmaceutical composition | |
| AU2001278705A1 (en) | Pharmaceutical composition | |
| AUPR529701A0 (en) | Pharmaceutical composition | |
| AU2002346223A1 (en) | Medicinal compositions | |
| AU2002361450A1 (en) | Novel pharmaceutical | |
| AU2001285737A1 (en) | Pharmaceutical compositions | |
| AUPS188302A0 (en) | Pharmaceutical composition | |
| AU2002100921A4 (en) | Pharmaceutical composition |